Yi Fang Group
10
10M
10
0.48
2
- Areas of investment
Summary
Yi Fang Group is the famous Corporate Investor, which was founded in 2001. The leading representative office of defined Corporate Investor is situated in the Beijing. The venture was found in Asia in China.
The top activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Yi Fang Group, startups are often financed by Winning Health Technology Group, Cenova Ventures. The meaningful sponsors for the fund in investment in the same round are Wanrong Capital, Vision Plus Capital, Telstra Ventures. In the next rounds fund is usually obtained by Vision Plus Capital, Tiger Global Management, Tencent Holdings.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight Fadada.com, VCBeat, Keyuan School. The fund has exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Public Relations, Hospital.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 2
- Rounds per year
- 0.48
- Investments by industry
- Health Care (4)
- Media and Entertainment (3)
- Software (2)
- Medical (2)
- SaaS (1) Show 17 more
- Investments by region
-
- China (9)
- United States (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Etong Health | 07 Dec 2017 | Health Care, Medical, Personal Health | Early Stage Venture | 15M | Shanghai, Xuhui, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.